Zobrazeno 1 - 10
of 254
pro vyhledávání: '"T.W.A. de Bruin"'
Publikováno v:
Journal of Lipid Research, Vol 40, Iss 6, Pp 1036-1044 (1999)
The apoAI-CIII-AIV gene cluster, located on chromosome 11, contributes to the phenotype of familial combined hyperlipidemia (FCH), but this contribution is genetically complex. Combinations of haplotypes, based on three restriction enzyme polymorphis
Externí odkaz:
https://doaj.org/article/f6274cbe209c492994c8c80ad3499bc2
Autor:
B. Hoebee, Chris T. Evelo, Edith J. M. Feskens, M.M.J. van Greevenbroek, M. Kruijshoop, V. M. M-J. Vermeulen, C.J.H. van der Kallen, T.W.A. de Bruin
Publikováno v:
Diabetic medicine 24 (2007) 5
Diabetic medicine, 24(5), 498-504
Diabetic Medicine, 24(5), 498-504. Wiley
Diabetic medicine, 24(5), 498-504
Diabetic Medicine, 24(5), 498-504. Wiley
AIMS: Thioredoxin interacting protein (TXNIP) is an attractive candidate gene for diabetes or diabetic dyslipidaemia, since TXNIP is the strongest glucose-responsive gene in pancreatic B-cells, TXNIP deficiency in a mouse model is associated with hyp
Autor:
T.W.A. de Bruin, Ellen E. Blaak, M. G. P. Magagnin, C.J.H. van der Kallen, Eva Corpeleijn, M. Kruijshoop, Wim H. M. Saris, Edith J. M. Feskens
Publikováno v:
Diabetic Medicine, 23(8), 907-911. Wiley
Diabetic medicine 23 (2006) 8
Diabetic medicine, 23(8), 907-911
Diabetic medicine 23 (2006) 8
Diabetic medicine, 23(8), 907-911
AIMS: The membrane-bound fatty acid transporter CD36/FAT may play a role in disturbed fatty acid handling as observed in the metabolic syndrome and Type 2 diabetes mellitus (T2DM). Genetic variation in the CD36 gene may contribute to the aetiology of
Autor:
Edith J. M. Feskens, Ellen E. Blaak, T.W.A. de Bruin, Eugène H.J.M. Jansen, Eva Corpeleijn, Marco Mensink, Wim H. M. Saris
Publikováno v:
Diabetologia, 49(10), 2392-2401. SPRINGER
Diabetologia, 49(10), 2392-2401. Springer, Cham
Diabetologia, 49(10), 2392-2401
Diabetologia 49 (2006) 10
Diabetologia, 49(10), 2392-2401. Springer, Cham
Diabetologia, 49(10), 2392-2401
Diabetologia 49 (2006) 10
Aims/hypothesis: The aim of this study was to investigate whether lifestyle intervention-induced changes in serum fatty acid profile of cholesteryl esters and estimated desaturase activities are related to improvements in insulin sensitivity in subje
Autor:
M. M. Schaap, Edith J. M. Feskens, B. Hoebee, T.W.A. de Bruin, Jacob C. Seidell, R.M. van Dam
Publikováno v:
Diabetic Medicine. 22:590-598
Aims To evaluate the relation between common variants in the ATP-sensitive K(+) channel genes and glucose intolerance. Methods We conducted a meta-analysis of reported association studies in Caucasian populations for common variants in the ABCC8 (exo
Autor:
Marco Mensink, Hubert Vidal, T.W.A. de Bruin, Wim H. M. Saris, Jan F. C. Glatz, Ellen E. Blaak
Publikováno v:
Diabetologia, 46(8), 1082-1089. Springer, Cham
Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance.Mensink M, Blaak EE, Vidal H, De Bruin TW, Glatz JF, Saris WH.Nutrition and Toxicology Research Institute Maastr
Publikováno v:
International Journal of Obesity 27 (2003) 3
International Journal of Obesity, 27(3), 377-384. Nature Publishing Group
International Journal of Obesity, 27(3), 377-384
International Journal of Obesity, 27(3), 377-384. Nature Publishing Group
International Journal of Obesity, 27(3), 377-384
Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year.Mensink M, Feskens EJ, Saris WH, De Bruin TW, Blaak EE.Department of Human Biology, Maastricht University, Maastricht, The Netherland
Publikováno v:
Atherosclerosis. 157(1):1-11
The relationship between variations in the apoAI-CIII-AIV gene cluster and plasma lipid traits has been recognized for at least 15 years. Most studies have been focused upon the association between plasma triglycerides and a genetic variation present
Publikováno v:
Atherosclerosis, 149(1), 25-31. Elsevier Ireland Ltd
Polarized Caco-2 cells can synthesize two distinct density classes of lipoproteins, i.e. chylomicron/VLDL (d
Publikováno v:
Diabetic Medicine, 16(6), 500-508. Wiley
Department of Internal Medicine, Utrecht University Hospital, The Netherlands.AIMS: To assess the feasibility of an intensive lipid-lowering strategy in diabetic subjects pursuing target plasma lipid levels. METHODS: Patients with diabetes mellitus (